Cytokine storm scale as a prognostic tool of course of viral pneumonia in COVID-19
- 作者: Tkachenko O.Y.1, Pervakova M.Y.1, Lapin S.V1, Masing A.V1, Moshnikova A.N1, Kuznetsova D.A1, Kholopova I.V1, Blinova T.V1, Surkova E.A1, Polushin Y.S1, Afanasiev A.A1, Shlyk I.V1, Gavrilova E.G1, Kornilova E.A2, Ivannikova D.A2, Trophimov E.A2, Mazurov V.I2
-
隶属关系:
- I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
- I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
- 期: 卷 7, 编号 6 (2021)
- 页面: 42-50
- 栏目: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288404
- DOI: https://doi.org/10.18565/therapy.2021.6.42-50
- ID: 288404
如何引用文章
详细
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
O. Tkachenko
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: tkachenie0mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
M. Pervakova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: margaritalerner@gmail.com
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
S. Lapin
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: svlapin0mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
A. Masing
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: alex_mazing0mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
A. Moshnikova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: moshnikova-anna@mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
D. Kuznetsova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: lariwar@mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
I. Kholopova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: irinakholopova@yandex.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
T. Blinova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: easurkova@mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
E. Surkova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: tvwinova@list.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
Yu. Polushin
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: polushinyus@1spbgmu.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
A. Afanasiev
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: alex-txf@mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
I. Shlyk
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: egavrilova70@mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
E. Gavrilova
I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of Russia
Email: irina_shlyk@mail.ru
197022, Saint Petersburg, 6/8 Lva Tolstogo Str. Tel.: +7 (812) 994-53-24, +7 (812) 338-71-94
E. Kornilova
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
Email: liza_kornilova@ьk.ru
191015, Saint Petersburg, 41 Kirochnaya Str. Tel.: +7 (921) 951-71-88
D. Ivannikova
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
Email: d.ivannikova@yandex.ru
191015, Saint Petersburg, 41 Kirochnaya Str. Tel.: +7 (921) 951-71-88
E. Trophimov
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
Email: evgeniy.trofimov@szgmu.ru
191015, Saint Petersburg, 41 Kirochnaya Str. Tel.: +7 (921) 951-71-88
V. Mazurov
I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia
Email: maz.nwgmu@yandex.ru
191015, Saint Petersburg, 41 Kirochnaya Str. Tel.: +7 (921) 951-71-88
参考
- Hu B., Guo H., Zhou P. et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021; 19(3): 141-54. doi: 10.1038/ s41579-020-00459-7.
- Guan W., Ni Z., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20. doi: 10.1056/NEJMoa2002032.
- Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229): 1054-62. doi: 10.1016/S0140-6736(20)30566-3.
- Tay M.Z., Poh C.M., Renia L. et al. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020; 20(6): 363-74. doi: 10.1038/s41577-020-0311-8.
- Li C., Zhao C., Bao J. et al. Laboratory diagnosis of coronavirus disease-2019 (COVID-19). Clin Chim Acta. 2020; 510: 35-46. doi: 10.1016/j.cca.2020.06.045.
- Han H., Ma Q., Li C. et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020; 9(1): 1123-30. doi: 10.1080/22221751.2020.1770129.
- Fan G., Tu C., Zhou F. et al. Comparison of severity scores for COVID-19 patients with pneumonia: A retrospective study. Eur Respir J. 2020; 56(3): 2002113. doi: 10.1183/13993003.02113-2020.
- Ткаченко О.Ю., Первакова М.Ю., Лапин С.В. с соавт. Прогностическая роль исследования цитокинов при COVID-19-ассоциированной пневмонии. Вестник Северо-Западного государственного университета им. И.И. Мечникова. 2021; 1: 59-69. @@Tkachenko O.Y., Pervakova M.Y., Lapin S V. et al. Prognostic value of cytokines in COVID-19 associated pneumonia. Vestnik Severo-Zapadnogo gosudarstvennogo universiteta im. I.I. Mechnikova = Bulletin of the Northwestern State University named after I.I. Mechnikov. 2021; 1: 59-69 (In Russ.). doi: https://dx.doi.org/10.17816/mechnikov61610.
- Satis H., Ozger H.S., Aysert Yildiz P. et al. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19. Cytokine. 2021; 137: 155302. doi: 10.1016/j.cyto.2020.155302.
- Crayne C.B., Albeituni S., Nichols K.E. et al. The immunology of macrophage activation syndrome. Front Immunol. 2019; 10: 119. doi: 10.3389/fimmu.2019.00119.
- Qin C., Zhou L., Hu Z. et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71(15): 762-68. doi: 10.1093/cid/ciaa248.
- Jamilloux Y., Henry T., Belot A. et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020; 19(7): 102567. doi: 10.1016/j.autrev.2020.102567.
- Coomes E.A., Haghbayan H. Interleukin6 in COVID-19: A systematic review and meta-analysis. Rev Med Virol. 2020; 30(6): 1-9. doi: 10.1002/rmv.2141.
- Lauw F.N., Pajkrt D., Hack C.E. et al. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol. 2000; 165(5): 2783-89. doi: 10.4049/jimmunol.165.5.278.
- Lu L., Zhang H., Dauphars D.J. et al. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol. 2021; 42(1): 3-5. doi: 10.1016/j.it.2020.10.012.
- Lippi G., Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta. 2020; 505: 190-91. doi: 10.1016/j.cca.2020.03.004.
- Song J., Park D.W, Moon S. et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019; 19(1): 968. doi: 10.1186/s12879-019-4618-7.
- Hu R., Han C., Pei S. et al. Procalcitonin levels in COVID-19 patients. Int J Antimicrob Agents. 2020; 56(2): 106051. doi: 10.1016/j. ijantimicag.2020.106051.
- Vanska M., Koivula I., Jantunen E. et al. IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients. Cytokine. 2012; 60(3): 787-92. doi: 10.1016/j.cyto.2012.07.023.
- Liang W., Liang H., Ou L. et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med. 2020; 180(8): 1081-89. doi: 10.1001/jamainternmed.2020.2033.
补充文件
![](/img/style/loading.gif)